Point72 Asset Management, L.P. 13D and 13G filings for Corbus Pharmaceuticals Holdings, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 7:48 pm Sale |
2024-09-30 | 13G | Corbus Pharmaceuticals Holdings, Inc. CRBP |
Point72 Asset Management, L.P. | 0 0.000% |
-388,676 (Position Closed) |
Filing |
| 2024-01-29 4:40 pm Purchase |
2024-01-26 | 13G | Corbus Pharmaceuticals Holdings, Inc. CRBP |
Point72 Asset Management, L.P. | 388,676 8.800% |
388,676 (New Position) |
Filing |